Skip to main content
Signal8

Bligh James

SEC insider (Form 3/4/5 filer). CIK 0001990748. Interim CFO at CONDUIT PHARMACEUTICALS INC. (CDT). 2 reported Form 4/5 transactions since Sep 2024; latest on Sep 19, 2025. Located in NAPLES, FL.

Companies Bligh James has filed insider reports for

  • CONDUIT PHARMACEUTICALS INC. (CDT): Director, Officer, Interim CFO
Bligh James profile photo

Bligh James

CIK: 0001990748

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CONDUIT PHARMACEUTICALS INC. logo
CDT

CONDUIT PHARMACEUTICALS INC.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • CDT Equity Inc. logo
    CDT

    CDT Equity Inc.

    Sep 19, 2025
    Award
    Direct
    480K shares-
  • CONDUIT PHARMACEUTICALS INC. logo
    CDT

    CONDUIT PHARMACEUTICALS INC.

    Nov 18, 2024
    Award

    Stock Option (Right to Buy)

    Direct
    1.9M shares at avg. $0.09-

1-2 of 2